UBS Knock-Out BIIB/ DE000UM4R5U1 /
| 8/2/2024 9:56:51 PM | Chg.-0.036 | Bid- | Ask- | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.091EUR | -28.35% | - Bid Size: - |
- Ask Size: - |
Biogen Inc | 198.0105 USD | 12/31/2078 | Call |
GlobeNewswire
7/2
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
7/1
Contact The Gross Law Firm by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
GlobeNewswire
7/1
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of U...
GlobeNewswire
6/30
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire
6/29
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Bio...
GlobeNewswire
6/29
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
6/28
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
6/28
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
GlobeNewswire
6/28
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
6/28
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
6/28
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
6/27
DEADLINE ALERT for BIIB, DRCT, FSLY, CRGE: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
6/27
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire
6/27
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
GlobeNewswire
6/27
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
6/26
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire
6/25
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit with the Schall Law Fir...
GlobeNewswire
6/25
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
GlobeNewswire
6/24
BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of U...
GlobeNewswire
6/24
TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union
GlobeNewswire
6/24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...
GlobeNewswire
6/22
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) – Contact Kessler Topaz M...
